Abstract
Atopic eczema is a mostly chronic, inflammatory, non-contagious skin disease that is accompanied by severe itching and often occurs in families, alone or in combination with asthma or allergic rhinoconjunctivitis. In most patients, IgE-mediated sensitizations to airborne or food allergens (extrinsic atopic eczema) can be detected. A distinction is made between a morphologically similar clinical picture in which neither specific IgE antibodies in the serum nor immediate-type reactions are detectable in the skin test against common aeroallergens (intrinsic atopic eczema). The prevalence of atopic eczema in Europe is 15–20% in children and 1.5–5% in adults. Scientific studies underline that in susceptible patients an epidermal barrier defect, together with microbial skin colonization and neuroimmunological processes, leads to an inflammatory response characterized by Th2, Th22, and Th1 cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bieber T, Simpson EL, Silverberg JI et al (2021) Abrocitinib versus placebo or dupilumab for atopic dermatitis. N Engl J Med 384(12):1101–1112
Boneberger S, Rupec RA, Ruzicka T (2010) Complementary therapy for atopic dermatitis and other allergic skin diseases: facts and controversies. Clin Dermatol 28:57–61
Elias PM, Schmuth M (2009) Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 9(4):265–272
Guttman-Yassky E, Thaçi D, Pangan AL et al (2019) Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial. J Allergy Clin Immunol 145(3):877–884
Heratizadeh A, Werfel T, Wollenberg A et al (2017) Effects of structured patient education in adult atopic dermatitis – multi-center randomized controlled trial. J Allergy Clin Immunol 140(3):845–853.e3. https://doi.org/10.1016/j.jaci.2017.01.029
Homey B, Steinhoff M, Ruzicka T et al (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118:178–189
Hompes S, Köhli A, Nemat K et al (2011) Provoking allergens and treatment of anaphylaxis in children and adolescents–data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol 22(6):568–74. PMID: 21435004. https://doi.org/10.1111/j.1399-3038.2011.01154.x. Epub 2011 Mar 16
Kitamura K (1966) On the problems of infantile eczema. Hautarzt 17(2):53–5
Kerschenlohr K, Decard S, Darsow U et al (2003) Clinical and immunologic reactivity to aeroallergens in “intrinsic” atopic dermatitis patients. J Allergy Clin Immunol 111:195–197
Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345–360
Morgan DB (1948) A suggestive sign of allergy. Arch Derm Syphilol 57(6):1050. PMID: 18098747. https://doi.org/10.1001/archderm.1948.01520190129018
Nemmer JM, Kuchner M, Datsi A, Oláh P, Julia V, Raap U, Homey B (2021) Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues. Front Med (Lausanne) 8:639097. PMID: 33644104. https://doi.org/10.3389/fmed.2021.639097. eCollection 2021
Reich K, Kabashima K, Peris K et al (2020) Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol 156(12):1333–1343
Ring J, Alomar A, Bieber T et al (2012a) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 26:1045–1060
Ring J, Alomar A, Bieber T et al (2012b) Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol 26:1176–1193
Ruëff F, Bergmann K-C, Brockow K et al (2010) Hauttests zur Diagnostik von allergischen Soforttyp-Reaktionen. Allergo J 19:402–415
Ruzicka T, Hanifin JM, Furue M et al (2017) Anti Interleukin-31 receptor A antibody for atopic dermatitis. N Engl J Med 376:826–835
Schmuth M, Feingold KR, Elias PM (2020) Stress test of the skin: the cutaneous permeability barrier treadmill. Exp Dermatol 29(1):112–113
Siegels D, Heratizadeh A, Abraham S et al (2021) Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. Allergy 76(4):1053–1076
Silverberg JI, Toth D, Bieber T, Alexis AF et al (2021) Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial. Br J Dermatol 184(3):450–463
Sutton RL (1956) Summertime pityriasis of the elbow and knee. in: Sutton Jr., R.L. Disease of the skin. 2nd ed. CV Mosby Co, St Louis (MO): 898
Simpson E, Bieber T, Guttman-Yassky E et al (2016) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375:2335–2348
Weidinger S, Novak N (2016) Atopic dermatitis. Lancet 387(10023):1109–1122
Weidinger S, Beck LA, Bieber T et al (2018) Atopic dermatitis. Nat Rev Dis Primers 4(1):1
Werfel T, Heratizadeh A, Aberer W et al (2016) S2k – Leitlinie Neurodermitis (atopisches Ekzem; atopische Dermatitis) – Kurzversion. J Dtsch Dermatol Ges 14:92–106
Wollenberg A, Vogel S (2013) Patch testing for noncontact dermatitis: the atopy patch test for food and inhalants. Curr Allergy Asthma Rep 5:539–544
Wollenberg A, Reitamo S, Girolomoni G et al (2008) Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 63:742–750
Wollenberg A, Oranje A, Deleuran M et al (2016) ETFAD eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and pediatric patients. J Eur Acad Dermatol Venereol 30:729–747
First Describer
Besnier E (1892) Première note et observations préliminaires pour servir d’introduction à l’étude diathésique. Ann Dermatol Syphiligr 3:634
Brocq L, Jacquet L (1891) Notes pour servir à l’histoire des névrodermites. Du lichen circumscriptus des anciens auteurs, ou lichen simplex chronique de M. le Dr. E. Vidal. Ann Dermatol Syphiligr. troisième série, tome II:193–208
Diepgen TL, Sauerbrei W, Fartasch M (1996) Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 49:1031–1038
European Task Force on Atopic Dermatitis (1993) Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 186:23–31
Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92:44–47
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Homey, B., Ruzicka, T., Wollenberg, A. (2022). Atopic Dermatitis. In: Plewig, G., French, L., Ruzicka, T., Kaufmann, R., Hertl, M. (eds) Braun-Falco´s Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63709-8_32
Download citation
DOI: https://doi.org/10.1007/978-3-662-63709-8_32
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-63708-1
Online ISBN: 978-3-662-63709-8
eBook Packages: MedicineReference Module Medicine